Condition: Major Depressive Episode · Sponsor: Assistance Publique - Hôpitaux de Paris
Despite international efforts to identify biomarkers of depression, none has been transferred to clinical practice, neither for diagnosis, evolution, nor therapeutic response. This led us to build a French national cohort (through the clinical and research network named SoPsy within the French biological psychiatry society (AFPBN) and sleep society (SFRMS)), to better identify markers of sleep and biological rhythms and validate more homogeneous subgroups of patients, but also to specify the manifestations and pathogeneses of depressive disorders.
This description comes directly from the study's public registry record.
Pierre Alexis GEOFFROY, PU-PH · 01 40 25 82 62 · Pierrealexis.geoffroy@aphp.fr
Julia MARUANI · julia.maruani@aphp.fr
Always discuss trial participation with your own doctor first.
| Hôpital Bichat Claude Bernard | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05866991